Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
Nichi-Iko Pharmaceutical Co., Ltd.
|
| gptkbp:acquisitionYear |
2016
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:founded |
2006
|
| gptkbp:founder |
Jeffrey M. Yordon
|
| gptkbp:headquartersLocation |
gptkb:Schaumburg,_Illinois,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sagent Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:parentCompany |
Nichi-Iko Pharmaceutical Co., Ltd.
|
| gptkbp:specializesIn |
injectable pharmaceuticals
|
| gptkbp:website |
https://www.sagentpharma.com/
|
| gptkbp:bfsParent |
gptkb:Village_of_Schaumburg
|
| gptkbp:bfsLayer |
7
|